Palliative Care in Castrate-Resistant Prostate Cancer

被引:9
|
作者
Rabow, Michael W. [1 ]
Lee, Michael Xiang [2 ]
机构
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Symptom Management Serv, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA
关键词
Palliative care; Castrate-resistant prostate cancer; Symptom management; QUALITY-OF-LIFE; CONTROLLED-TRIAL; MEN; HOSPICE; IMPACT; SURVIVAL; OUTCOMES; SERVICE; NEEDS; END;
D O I
10.1016/j.ucl.2012.07.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Significant symptoms and suffering related to castrate-resistant prostate cancer (CRPC) are associated with the disease and its treatment. Increasingly, with advances in treatment efficacy, men can live with symptoms for long periods. Interdisciplinary palliative care teams (including physicians, nurses, social workers, chaplains, pharmacists, psychologists, physical therapists, and nutritionists) focused on symptom management and patients' goals of care can collaborate with prostate cancer surgeons, oncologists, and radiation oncologists to provide the best care for men at all stages of treatment, including end of life. This article reviews the benefits of palliative care in helping patients with CRPC manage symptoms and distress.
引用
收藏
页码:491 / +
页数:14
相关论文
共 50 条
  • [31] New Therapeutics to Treat Castrate-Resistant Prostate Cancer
    Acar, Omer
    Esen, Tarik
    Lack, Nathan A.
    SCIENTIFIC WORLD JOURNAL, 2013,
  • [32] Incidence of dural metastases in castrate-resistant prostate cancer
    Khondker, Adree
    Kwong, Jethro C. C.
    Tran, Christopher
    Evans, Emily
    Aditya, Ishan
    Raveendran, Lucshman
    Chen, Yingming A.
    Ali, Amna
    Feifer, Andrew
    JOURNAL OF CLINICAL UROLOGY, 2024, 17 (04) : 378 - 385
  • [33] Symptom Clusters in Men With Castrate-Resistant Prostate Cancer
    Vayne-Bossert, Petra
    Hardy, Janet
    Skerman, Helen
    Yates, Patsy
    Sullivan, Karyn
    Good, Phillip
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2017, 54 (03) : E1 - E3
  • [34] Changing Therapeutic Paradigms in Castrate-Resistant Prostate Cancer
    Zivi, Andrea
    Massard, Christophe
    De-Bono, Johann
    CLINICAL GENITOURINARY CANCER, 2010, 8 (01) : 17 - 22
  • [35] New horizons in the management of castrate-resistant prostate cancer
    Kamel, Mohamed H.
    Raheem, Omer A.
    Davis, Rodney
    JOURNAL OF CLINICAL UROLOGY, 2018, 11 (04) : 258 - 265
  • [36] Management of castrate-resistant prostate cancer in older men
    Ged, Yasser
    Horgan, Anne M.
    JOURNAL OF GERIATRIC ONCOLOGY, 2016, 7 (02) : 57 - 63
  • [37] Metastatic Castrate-Resistant Prostate Cancer Practical Review
    Moeller, Abby
    Cookson, Michael
    Patel, Sanjay G.
    PHYSICIAN ASSISTANT CLINICS, 2018, 3 (01) : 11 - +
  • [38] Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer
    Dayyani, Farshid
    Gallick, Gary E.
    Logothetis, Christopher J.
    Corn, Paul G.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (22): : 1665 - 1675
  • [39] Potential role of rituximab in metastatic castrate-resistant prostate cancer
    Bindal, Poorva
    Jalil, Sharif A. A.
    Holle, Lisa M.
    Clement, Jessica M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (06) : 1509 - 1511
  • [40] Treatment of castrate-resistant prostate cancer - What is the best management?
    Uemura, Hirotsugu
    Reiter, Robert
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (04) : 427 - 427